Advertisement
Advertisement
U.S. Markets close in 4 hrs 22 mins
Advertisement
Advertisement
Advertisement
Advertisement

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.65-0.22 (-2.02%)
As of 11:37AM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/9/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.26
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.32
52 Week Low 34.81
50-Day Moving Average 38.08
200-Day Moving Average 37.35

Share Statistics

Avg Vol (3 month) 31.55M
Avg Vol (10 day) 31.86M
Shares Outstanding 5103.12M
Implied Shares Outstanding 6N/A
Float 886.65M
% Held by Insiders 17.54%
% Held by Institutions 171.38%
Shares Short (Jul 14, 2022) 48.84M
Short Ratio (Jul 14, 2022) 45.99
Short % of Float (Jul 14, 2022) 49.30%
Short % of Shares Outstanding (Jul 14, 2022) 48.60%
Shares Short (prior month Jun 14, 2022) 49.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 29.31%
Operating Margin (ttm)39.00%

Management Effectiveness

Return on Assets (ttm)16.87%
Return on Equity (ttm)22.59%

Income Statement

Revenue (ttm)153.72M
Revenue Per Share (ttm)1.49
Quarterly Revenue Growth (yoy)42.70%
Gross Profit (ttm)102.01M
EBITDA 60.08M
Net Income Avi to Common (ttm)45.06M
Diluted EPS (ttm)0.39
Quarterly Earnings Growth (yoy)72.80%

Balance Sheet

Total Cash (mrq)197.8M
Total Cash Per Share (mrq)1.92
Total Debt (mrq)4.13M
Total Debt/Equity (mrq)1.88
Current Ratio (mrq)9.64
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)65.04M
Levered Free Cash Flow (ttm)47.04M
Advertisement
Advertisement